A, J., SA, K., V, S., & P, R. (2026). IDH enzyme inhibition in cancer therapy: Mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma. 3 Biotech, 16(4), 137. https://doi.org/10.1007/s13205-026-04753-8
Chicago Style (17th ed.) CitationA, Josephine, Kumar SA, Sureka V, and Rajendran P. "IDH Enzyme Inhibition in Cancer Therapy: Mechanisms, Mutational Insights, and Effects of IDH Inhibitors in Glioma, Acute Myeloid Leukemia and Chondrosarcoma." 3 Biotech 16, no. 4 (2026): 137. https://doi.org/10.1007/s13205-026-04753-8.
MLA (9th ed.) CitationA, Josephine, et al. "IDH Enzyme Inhibition in Cancer Therapy: Mechanisms, Mutational Insights, and Effects of IDH Inhibitors in Glioma, Acute Myeloid Leukemia and Chondrosarcoma." 3 Biotech, vol. 16, no. 4, 2026, p. 137, https://doi.org/10.1007/s13205-026-04753-8.